Delayed Renal Allograft Function and Furosemide Treatment
Status:
Withdrawn
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This study will be a randomized prospective double-blind placebo-controlled clinical pilot
trial. This will be a single center project that will take place at Loma Linda University
Medical Center. All adult kidney recipients will be informed of the study prior to operation.
The Nephrology fellows or attending physicians will attempt to obtain informed consent from
all eligible patients, pre-transplant. Those patients who consent will be screened post
operation for enrollment. Patients who do not meet all eligibility criteria and/or who meet
some exclusion criteria will be deemed ineligible for the trial, and will be excluded. The
Nephrology and Transplant teams will be blinded of patient assignment and only the pharmacy
will know the patient's assignment.